Advancing vein care with a first-of-its-kind replacement valve for veins

THE CONDITION

Poorly functioning vein valves

THE NEED

Over 10% of the U.S. is affected by poorly functioning valves in the veins of legs and advanced vein disease.

These poorly functioning valves allow blood to flow backward and pool in the legs.
This pooling causes swelling, pain, and recurring leg wounds.
Still, there is no definitive cure.

Recurring leg wounds affect millions in the United States alone.
Management costs billions to the U.S. healthcare system annually.
Current treatment is palliative, leaving up to half this population with recurrent wounds for years to decades.
Others often remain with advanced symptoms including pain, leg swelling, and skin thickening.
Still, there is no option for a prosthetic valve replacement on the market.

THE SOLUTION

InnoVein, a Y Combinator and venture backed medical device company, is developing a first-of-its-kind valve replacement to offer patients their first definitive cure. Its novel award-winning technology is predicated on decades of cardiac and arterial approaches.

THE TEAM

In aggregate, the InnoVein founding team has invented and brought over 15 medical technologies to market, with leading products selling over $3B. Track record:

Invented and developed cardiovascular products that are standard of care - used in over 2 million patients to date.
Founded and successfully led multiple medical device companies to market and acquisition.
Served senior level positions at top-tier medical device companies.
Holds over 200 patents.

THE CONDITION

THE NEED

THE SOLUTION

THE TEAM

RECOGNITION & AWARDS